Similar articles for PMID: 7906729

Year	Number of Results
1988	3
1989	1
1990	2
1991	5
1992	4
1993	17
1994	3
1995	3
1996	3
1997	7
1998	5
1999	3
2000	5
2001	2
2002	3
2003	3
2004	4
2005	5
2006	1
2010	1
2011	1
2012	1
2014	1
2020	1
2022	0

1

Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.

Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Rao VV, et al. J Nucl Med. 1994 Mar;35(3):510-5. J Nucl Med. 1994. PMID: 7906729 Free article.

2

Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.

Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Piwnica-Worms D, et al. Cancer Res. 1993 Mar 1;53(5):977-84. Cancer Res. 1993. PMID: 8094997

3

Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates.

Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA, Thorgeirsson SS. Schrenk D, et al. Hepatology. 1993 May;17(5):854-60. Hepatology. 1993. PMID: 8098315

4

Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.

Chaudhary PM, Roninson IB. Chaudhary PM, et al. Oncol Res. 1992;4(7):281-90. Oncol Res. 1992. PMID: 1360276

5

Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells.

Márián T, Balkay L, Trón L, Krasznai ZT, Szabó-Péli J, Krasznai Z. Márián T, et al. Eur J Pharm Sci. 2005 Apr;24(5):495-501. doi: 10.1016/j.ejps.2005.01.012. Eur J Pharm Sci. 2005. PMID: 15784339

6

Biphasic accumulation kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile in tumour cells and its modulation by lipophilic P-glycoprotein ligands.

Márián T, Balkay L, Szabó G, Krasznai ZT, Hernádi Z, Galuska L, Szabó-Péli J, Esik O, Trón L, Krasznai Z. Márián T, et al. Eur J Pharm Sci. 2005 Jun;25(2-3):201-9. doi: 10.1016/j.ejps.2005.02.010. Epub 2005 Mar 16. Eur J Pharm Sci. 2005. PMID: 15911215

7

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.

Pichler A, Zelcer N, Prior JL, Kuil AJ, Piwnica-Worms D. Pichler A, et al. Clin Cancer Res. 2005 Jun 15;11(12):4487-94. doi: 10.1158/1078-0432.CCR-05-0038. Clin Cancer Res. 2005. PMID: 15958634 Free article.

8

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.

Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H. Wong M, et al. Clin Pharmacol Ther. 2005 Jan;77(1):33-42. doi: 10.1016/j.clpt.2004.09.002. Clin Pharmacol Ther. 2005. PMID: 15637529

9

Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.

Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D. Crankshaw CL, et al. J Nucl Med. 1998 Jan;39(1):77-86. J Nucl Med. 1998. PMID: 9443741 Free article.

10

Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.

Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Piwnica-Worms D, et al. Biochemistry. 1995 Sep 26;34(38):12210-20. doi: 10.1021/bi00038a015. Biochemistry. 1995. PMID: 7547962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed